Dynamics of Borrelial Antibodies in European Lyme Borreliosis Patients with Erythema Migrans
Medical Sciences · 2026
DOI: 10.3390/medsci14050563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, 2026. Verfasst von Petra Bogovič und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, University Medical Centre Ljubljana, 1525 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Antibodies, Bacterial, Lyme Disease, Erythema Chronicum Migrans, Borrelia burgdorferi. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovenian Research and Innovation Agency.
Abstract (Originalsprache)
Background/Objectives: The diagnosis of typical erythema migrans (EM) is clinical, and serological testing for Borrelia-specific antibodies is not required. However, characterization of the immune response in patients with a reliable clinical diagnosis may improve the interpretation of serological findings in early Lyme borreliosis (LB) without characteristic skin lesions.
Methods
Serum IgM and IgG antibodies to Borrelia burgdorferi sensu lato were evaluated in 1356 Slovenian adults with EM at baseline and at a follow-up visit approximately two months after treatment initiation, using a chemiluminescence immunoassay based on recombinant borrelial antigens.
Results
At baseline, 41.5% of patients were IgM-seropositive, 55.5% IgG-seropositive, and 70.1% positive for either IgM or IgG. Patients with multiple EM were significantly more often seropositive than those with solitary EM. In previously untreated patients, baseline IgG seropositivity showed a clearer positive association with longer lesion duration and larger lesion diameter, whereas the corresponding IgM patterns were less consistent. Multiple EM remained strongly associated with both IgM and IgG seropositivity in adjusted analyses. Seroconversion at follow-up was uncommon, occurring in 8.0% of initially IgM-negative and 8.2% of initially IgG-negative patients.
Conclusions
The low frequency of newly detectable antibody responses indicates that repeat qualitative serologic testing approximately two months after treatment initiation provides limited additional diagnostic information in European adults with EM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, University Medical Centre Ljubljana, 1525 Ljubljana, Slovenia.
- Centre for Clinical Research, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
- Institute of Microbiology and Immunology, Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
ORCID-Profile: Martina Jaklič, Katarina Ogrinc, Franc Strle
Förderung
- The Slovenian Research and Innovation Agency
Zitieren
APA
Bogovič, P., Jaklič, M., Ogrinc, K., Maraspin, V., Rojko, T., Nahtigal-Klevišar, M., Ružić-Sabljić, E., Wormser, G. P., & Strle, F. (2026). Dynamics of Borrelial Antibodies in European Lyme Borreliosis Patients with Erythema Migrans. Medical Sciences. https://doi.org/10.3390/medsci14050563
Vancouver
Bogovič P, Jaklič M, Ogrinc K, Maraspin V, Rojko T, Nahtigal-Klevišar M, et al. Dynamics of Borrelial Antibodies in European Lyme Borreliosis Patients with Erythema Migrans. Medical Sciences. 2026. doi:10.3390/medsci14050563
BibTeX
@article{Bogovi2026,
author = {Bogovič, Petra and Jaklič, Martina and Ogrinc, Katarina and Maraspin, Vera and Rojko, Tereza and Nahtigal-Klevišar, Mirijam and Ružić-Sabljić, Eva and Wormser, Gary P and Strle, Franc},
title = {Dynamics of Borrelial Antibodies in European Lyme Borreliosis Patients with Erythema Migrans},
journal = {Medical Sciences},
year = {2026},
doi = {10.3390/medsci14050563}
}
EUVIMED